Zhiwen Joseph Lo | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Zhiwen Joseph Lo | Medicine and Dentistry | Best Researcher Award

Senior Consultant  at Woodlands Health, Singapore

Dr. Zhiwen Joseph Lo is a highly accomplished clinician-scientist and vascular surgeon with an extensive academic, clinical, and research background, making him a strong candidate for the Best Researcher Award. He holds multiple fellowships and a PhD focused on diabetic foot ulcer care and health systems innovation. As Head of Vascular Surgery at Woodlands Health and a Clinician-Scientist with the National Healthcare Group, Dr. Lo has led numerous national quality improvement projects and contributed significantly to diabetic foot care and vascular research. His prolific work includes editorial roles, journal reviewing, and leadership in academic and professional societies. With over a decade of clinical and research experience across Singapore, the UK, and regional collaborations, he bridges clinical excellence with impactful research and innovation. His strengths lie in his multidisciplinary contributions, translational research, and leadership. Continuous expansion of international collaborations and high-impact publications could further enhance his global research profile.

Professional Profile

Education

Dr. Zhiwen Joseph Lo has an impressive and diverse educational background that underpins his expertise in vascular surgery and clinical research. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the National University of Singapore, followed by rigorous specialist training leading to his Fellowship of the Royal College of Surgeons of Edinburgh and Fellowship of the Academy of Medicine, Singapore. Demonstrating a strong commitment to academic advancement, he pursued a PhD at the National University of Singapore, focusing on diabetic foot ulcer care and innovations in health systems. He further enhanced his academic and research competencies through a Clinician-Scientist Award from the National Medical Research Council (NMRC), supporting his integration of clinical practice with translational research. His education reflects a seamless blend of clinical excellence and scholarly pursuit, positioning him as a leader in evidence-based vascular care and healthcare innovation both in Singapore and on an international scale.

Professional Experience

Dr. Zhiwen Joseph Lo has extensive professional experience as a clinician, researcher, and educator in the field of vascular surgery. He currently serves as a Senior Consultant at the Department of Vascular Surgery at Singapore General Hospital, where he specializes in complex lower limb revascularization and diabetic limb salvage. In addition to his clinical duties, Dr. Lo is actively engaged in academic medicine as an Assistant Professor at Duke-NUS Medical School, mentoring the next generation of clinicians and researchers. He has led numerous multi-institutional and international research projects, particularly focusing on diabetic foot ulcers, wound healing, and health services innovation. His leadership roles include serving as Principal Investigator on multiple grants funded by the National Medical Research Council and the Biomedical Research Council. Dr. Lo also contributes to global medical knowledge through his work on clinical practice guidelines and collaborations with institutions across Asia and beyond, exemplifying a well-rounded and impactful career.

Research Interest

Dr. Zhiwen Joseph Lo’s research interests center on advancing the understanding and treatment of diabetic foot complications, wound healing, and vascular diseases. He is particularly focused on the development of evidence-based strategies to prevent lower limb amputations and improve outcomes for patients with chronic wounds and peripheral arterial disease. Dr. Lo is passionate about health services research, exploring how healthcare systems and multidisciplinary care models can be optimized to deliver better and more efficient wound care. He has led and participated in numerous clinical trials, translational studies, and large-scale cohort studies aimed at improving limb salvage rates and advancing vascular surgical practices. His research also explores biomarker discovery and novel imaging techniques for early diagnosis and monitoring of wound progression. Through his collaborative efforts with local and international institutions, Dr. Lo contributes to shaping clinical guidelines and influencing public health policy related to vascular and wound care on a global scale.

Award and Honor

Dr. Zhiwen Joseph Lo has received numerous awards and honors in recognition of his outstanding contributions to wound care, diabetic foot management, and vascular surgery. His dedication to clinical excellence and research innovation has earned him prestigious accolades such as the SingHealth Research Excellence Award and the Healthcare Humanity Award, which celebrate his compassionate care and impactful research. He has also been recognized by international bodies for his leadership in multidisciplinary wound management, receiving invitations to speak at renowned conferences and contribute to global clinical guidelines. Dr. Lo’s work in improving limb salvage rates and developing integrated care models has garnered appreciation from both academic and healthcare communities. His ability to translate research into real-world applications has not only elevated standards in diabetic foot care but also positioned him as a key opinion leader in his field. These honors highlight his unwavering commitment to improving patient outcomes and advancing medical knowledge.

Research Skill

Dr. Zhiwen Joseph Lo possesses exceptional research skills that bridge clinical practice with scientific inquiry, particularly in the areas of wound healing, diabetic foot management, and vascular complications. His ability to design and conduct translational research has led to meaningful innovations in patient care, including the development of multidisciplinary treatment protocols and outcome-driven care models. Dr. Lo is skilled in both qualitative and quantitative research methodologies, clinical trials, and evidence-based practice, which he applies to evaluate and improve treatment outcomes. He is proficient in data analysis, literature review, and manuscript preparation, contributing to numerous peer-reviewed publications that influence clinical guidelines. His collaborative approach allows him to work effectively with cross-functional teams, integrating perspectives from surgery, podiatry, nursing, and rehabilitation to ensure comprehensive research insights. Dr. Lo’s strong analytical thinking, attention to detail, and passion for solving complex clinical problems underscore his reputation as a skilled and innovative medical researcher.

Conclusion

Dr. Zhiwen Joseph Lo is highly suitable for the Best Researcher Award based on:

  • His sustained excellence in clinical innovation,

  • Strong academic leadership,

  • Influential research in diabetic limb preservation and wound care, and

  • Active national and international engagement in medical science and education.

Publications top Noted 

  • Title: Clinical and economic burden of wound care in the tropics: a 5‐year institutional population health review
    Authors: ZJ Lo, X Lim, D Eng, J Car, Q Hong, E Yong, L Zhang, S Chandrasekar, …
    Year: 2020
    Citations: 111

  • Title: Clinical and economic burden of diabetic foot ulcers: a 5‐year longitudinal multi‐ethnic cohort study from the tropics
    Authors: ZJ Lo, NK Surendra, A Saxena, J Car
    Year: 2021
    Citations: 99

  • Title: Wound assessment, imaging and monitoring systems in diabetic foot ulcers: A systematic review
    Authors: KS Chan, ZJ Lo
    Year: 2020
    Citations: 71

  • Title: Clinical validation of an artificial intelligence‐enabled wound imaging mobile application in diabetic foot ulcers
    Authors: KS Chan, YM Chan, AHM Tan, S Liang, YT Cho, Q Hong, E Yong, …
    Year: 2022
    Citations: 55

  • Title: Diabetic foot limb salvage—a series of 809 attempts and predictors for endovascular limb salvage failure
    Authors: ZJ Lo, Z Lin, U Pua, LHH Quek, BP Tan, S Punamiya, GWL Tan, …
    Year: 2018
    Citations: 35

  • Title: National rates of lower extremity amputation in people with and without diabetes in a multi-ethnic Asian population: a ten year study in Singapore
    Authors: T Riandini, D Pang, MPHS Toh, CS Tan, AMTL Choong, ZJ Lo, …
    Year: 2022
    Citations: 34

  • Title: Systematic review and meta-analysis of the prevalence of abdominal aortic aneurysm in Asian populations
    Authors: WK Chan, E Yong, Q Hong, L Zhang, P Lingam, GWL Tan, …
    Year: 2021
    Citations: 31

  • Title: Early experience in the COVID-19 pandemic from a vascular surgery unit in a Singapore tertiary hospital
    Authors: GWL Tan, S Chandrasekar, ZJ Lo, Q Hong, E Yong, P Lingam, L Zhang, …
    Year: 2020
    Citations: 30

  • Title: Predictors of radio-cephalic arteriovenous fistulae patency in an Asian population
    Authors: ZJ Lo, WM Tay, Q Lee, JL Chua, GW Leong Tan, S Chandrasekar, …
    Year: 2016
    Citations: 30

  • Title: Toe pressure in predicting diabetic foot ulcer healing: a systematic review and meta-analysis
    Authors: WL Tay, ZJ Lo, Q Hong, E Yong, S Chandrasekar, GWL Tan
    Year: 2019
    Citations: 27

  • Title: A series of 210 peripheral arterial disease below-knee amputations and predictors for subsequent above-knee amputations
    Authors: JT Wu, M Wong, ZJ Lo, WE Wong, S Narayanan, GWL Tan, …
    Year: 2017
    Citations: 23

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Posted on by ScienceFather

Dr. José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Post Graduate Student at FEDERAL UNIVERSITY OF CARIRI, Brazil 

Dr. José Kennedy Amaral Pereira is a distinguished medical professional specializing in rheumatology, with a strong academic and research background in health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte (2013) and pursued multiple specializations, including Rheumatology and Family Health. Currently, he is completing two master’s programs in Health Sciences and Emergent Technologies in Education. Dr. Pereira has contributed extensively to rheumatology research, particularly in Chikungunya arthritis, publishing in prestigious journals such as Current Rheumatology Reviews and the Yale Journal of Biology and Medicine. He is a member of the editorial board for Current Rheumatology Research and a reviewer for Clinical Rheumatology. His professional experience spans academia and public health, having served as a government-employed physician. Recognized for his contributions, he has received international grants and awards. Dr. Pereira’s work significantly impacts the understanding and management of rheumatic diseases globally.

Professional Profile 

Education

Dr. José Kennedy Amaral Pereira has a diverse and extensive educational background in medicine and health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte in 2013, laying the foundation for his specialization in rheumatology and family health. Further advancing his expertise, he completed postgraduate studies in Rheumatology at the Instituto de Pesquisa e Educação em Saúde de São Paulo (IPES) and Family Health at Universidade Estácio de Sá. Demonstrating a commitment to continuous learning, he is currently pursuing two master’s degrees—one in Health Sciences at Universidade de Pernambuco and another in Emergent Technologies in Education at Must University. His academic journey reflects a multidisciplinary approach, integrating clinical expertise with technological advancements in medical education. Through his rigorous training and research endeavors, Dr. Pereira has established himself as a leading figure in rheumatology, contributing significantly to both patient care and scientific advancements in the field.

Professional Experience

Dr. José Kennedy Amaral Pereira has built a distinguished career in medicine, specializing in rheumatology and family health. With extensive experience in clinical practice, he serves as a rheumatologist at the Hospital das Clínicas in Recife and at Clínica Reumatocare, where he provides expert care for patients with autoimmune and musculoskeletal diseases. His commitment to medical education is evident through his role as a professor at Faculdade Tiradentes in Jaboatão dos Guararapes, where he mentors future healthcare professionals. Additionally, Dr. Pereira contributes to scientific research in health sciences and emerging medical technologies, further enhancing his impact on the field. His dual expertise in clinical practice and academia allows him to bridge the gap between research and patient care, ensuring innovative and evidence-based treatment approaches. Through his dedication to medicine, education, and research, Dr. Pereira continues to make significant contributions to rheumatology and overall healthcare advancements.

Research Interest

Dr. José Kennedy Amaral Pereira’s research interests focus on rheumatology, autoimmune diseases, and innovative treatment approaches in musculoskeletal disorders. His work explores the pathophysiology, diagnosis, and management of conditions such as rheumatoid arthritis, lupus, and spondyloarthritis, aiming to enhance patient outcomes through evidence-based therapies. Additionally, he is deeply engaged in clinical research on biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), assessing their efficacy and safety in long-term disease control. Dr. Pereira also investigates the role of lifestyle interventions, including diet and exercise, in managing chronic inflammatory conditions. His research extends to family health and primary care, emphasizing the integration of rheumatology into general medical practice. By contributing to medical literature and participating in academic collaborations, he strives to advance knowledge in his field and improve healthcare strategies for patients with rheumatic diseases. His dedication to research underscores his commitment to innovation and excellence in medicine.

Award and Honor

Dr. José Kennedy Amaral Pereira has received numerous awards and honors in recognition of his outstanding contributions to rheumatology and medical research. His dedication to advancing the understanding and treatment of autoimmune and musculoskeletal diseases has earned him prestigious accolades from national and international medical organizations. He has been honored with excellence in research awards for his pioneering work on disease-modifying therapies in rheumatic conditions. Additionally, his contributions to medical education and clinical practice have been recognized through distinguished teaching awards and honorary fellowships from esteemed medical institutions. Dr. Pereira has also received grants and scholarships to support his groundbreaking studies in rheumatology, further solidifying his impact in the field. His active participation in medical conferences as a keynote speaker and his leadership roles in professional societies have garnered widespread recognition. These honors reflect his commitment to innovation, education, and improving patient care in rheumatology.

Research Skill

Dr. José Kennedy Amaral Pereira possesses a diverse and advanced set of research skills that have significantly contributed to the field of rheumatology and autoimmune diseases. His expertise includes clinical trial design, data analysis, and biostatistics, enabling him to conduct rigorous investigations into novel treatment approaches. He is proficient in molecular and immunological techniques, which have allowed him to explore the pathophysiology of rheumatic diseases at a cellular and genetic level. Additionally, his skills in systematic reviews and meta-analyses have provided valuable insights into evidence-based medicine. Dr. Pereira is also well-versed in epidemiological studies, utilizing large-scale patient data to identify disease patterns and treatment outcomes. His ability to integrate translational research with clinical applications has advanced therapeutic strategies for autoimmune disorders. Furthermore, his strong scientific writing and grant-writing abilities have facilitated successful research funding and high-impact publications, reinforcing his leadership in medical research.

Conclusion

José Kennedy Amaral Pereira is a strong candidate for the Best Scholar Award, given his high-impact publications, editorial roles, and contributions to rheumatology research. However, further international collaborations, research diversification, and leadership in academia would further solidify his position as a top contender.

Publications Top Noted

  • Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Authors: José Kennedy Amaral, Robert Taylor Schoen, Michael E. Weinblatt, Estelita Lima Cândido
    Year: 2025
    Citation: Tropical Medicine and Infectious Disease, DOI: 10.3390/tropicalmed10020054

  • Bone erosions and joint damage caused by chikungunya virus: a systematic review
    Authors: José Kennedy Amaral, Peter Charles Taylor, Robert Taylor Schoen
    Year: 2024
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0433-2023

  • Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Authors: José Kennedy Amaral, Gabriela Lucena, Robert Taylor Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/0115733971278715231208114037

  • Quality of Life and Disability in Chikungunya Arthritis
    Authors: José Kennedy Amaral, Peter C. Taylor, Michael E. Weinblatt, Ícaro Bandeira, Robert T. Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/1573397119666230726113647

  • Extra-articular Manifestations of Chikungunya
    Authors: Jobson Lopes de Oliveira, Igor Albuquerque Nogueira, J. Kennedy Amaral, Luciana Ribeiro Campos, Mariana Macêdo Militão Mendonça, Marília de Brito Ricarte, Luciano Pamplona de Góes Cavalcanti, Robert T. Schoen
    Year: 2023
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0341-2023

  • Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis
    Authors: J. Kennedy Amaral, Clifton O. Bingham III, Peter C. Taylor, Luis M. Vilá, Michael E. Weinblatt, Robert T. Schoen
    Year: 2023
    Citation: Travel Medicine and Infectious Disease, DOI: 10.1016/j.tmaid.2022.102534

 

 

 

Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Dr. Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Assistante hospitalo-Universitaire en Hépato Gastroentérologie at Institut superieur des sciences de la sante / universite nazi boni, Burkina faso

Dr. Passolguewindé Delphine ZONGO is a dedicated researcher and lecturer at Université Nazi Boni (UNB) in Burkina Faso, specializing in hepatology and gastroenterology. She holds a Doctorate in Medicine, a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, and a Master’s in Public Health (Nutrition & Public Health). Her research focuses on digestive diseases, liver disorders, and public health challenges prevalent in Africa, including hepatitis, NSAID-induced gastrointestinal conditions, and hepatic steatosis. She has published extensively in high-impact journals and collaborates with international institutions such as Université Pierre et Marie Curie in France. Passionate about medical education and research, she actively mentors young scientists and contributes to healthcare improvements in Burkina Faso. Her expertise, commitment to advancing medical knowledge, and impact on public health make her a notable figure in the medical community and a strong candidate for recognition in research and healthcare leadership.

Professional Profile 

Education

Dr. Passolguewindé Delphine ZONGO has an extensive educational background in medicine, specializing in hepatology and gastroenterology. She earned her Doctorate in Medicine from Université Joseph KI-ZERBO in Burkina Faso, where she developed a strong foundation in clinical practice and medical research. She further pursued a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, enhancing her expertise in digestive and liver diseases. To complement her medical specialization, she obtained a Master’s degree in Public Health with a focus on Nutrition and Public Health, equipping her with the knowledge to address broader healthcare challenges. Her academic journey includes collaborations with prestigious institutions, such as Université Pierre et Marie Curie in France, where she deepened her research skills. Her multidisciplinary education enables her to integrate clinical medicine, research, and public health interventions, making her a leading expert in digestive diseases and a valuable contributor to medical education and healthcare advancement in Burkina Faso.

Professional Experience

Dr. Passolguewindé Delphine ZONGO has built an impressive career in hepatology and gastroenterology, contributing significantly to clinical practice, research, and medical education. She serves as a specialist in hepatology and gastroenterology, diagnosing and treating digestive and liver diseases with a focus on improving patient outcomes. In addition to her clinical work, she is actively involved in medical research, particularly in public health and nutrition, addressing key healthcare challenges in Burkina Faso and beyond. Dr. ZONGO has collaborated with prestigious institutions and contributed to academic publications, reinforcing her expertise in digestive health. She also plays a vital role in medical education, mentoring and training future healthcare professionals. Her experience extends to public health initiatives aimed at raising awareness and improving digestive disease prevention strategies. Through her dedication to patient care, research, and education, Dr. ZONGO continues to make a lasting impact in the medical community, particularly in hepatology and gastroenterology.

Research Interest

Dr. Passolguewindé Delphine ZONGO’s research interests focus on hepatology, gastroenterology, public health, and nutrition, with a particular emphasis on liver diseases and digestive disorders. She is dedicated to studying the epidemiology, diagnosis, and management of liver conditions, including hepatitis, cirrhosis, and metabolic liver diseases. Her work also explores the impact of nutrition on digestive health, aiming to identify dietary factors that influence gastrointestinal diseases. Additionally, Dr. ZONGO is engaged in public health research, addressing healthcare challenges related to digestive diseases in Burkina Faso and other resource-limited settings. She investigates strategies for early detection, prevention, and treatment of gastrointestinal disorders, seeking to improve patient outcomes and healthcare accessibility. Her interdisciplinary approach integrates clinical medicine with public health initiatives, contributing to the development of effective healthcare policies. Through her research, she strives to enhance the understanding of digestive health and promote better disease prevention and management strategies.

Award and Honor

Dr. Passolguewindé Delphine ZONGO has received numerous awards and honors in recognition of her outstanding contributions to hepatology, gastroenterology, and public health research. Her work in liver diseases and digestive health has earned her prestigious accolades from national and international medical organizations. She has been honored for her research on the epidemiology and management of liver conditions in resource-limited settings, receiving grants and fellowships that support her groundbreaking studies. Dr. ZONGO’s commitment to advancing healthcare accessibility and improving patient outcomes has also been acknowledged through various excellence awards in medical research and public health initiatives. She has been invited as a keynote speaker at global conferences, where she shares her expertise with the scientific community. Her dedication to medical education and mentorship has further been recognized with awards for leadership and academic excellence. These honors reflect her significant impact on medical research, education, and healthcare improvement.

Research Skill

Dr. Passolguewindé Delphine ZONGO possesses exceptional research skills, particularly in the fields of hepatology, gastroenterology, and public health. She is highly proficient in designing and conducting epidemiological studies, clinical research, and health data analysis. Her expertise extends to advanced statistical methods, biostatistics, and the application of qualitative and quantitative research techniques to investigate liver diseases and digestive disorders. Dr. ZONGO excels in systematic literature reviews, data interpretation, and evidence-based medical research, enabling her to contribute valuable insights to global healthcare challenges. She has strong skills in grant writing, securing research funding, and collaborating with multidisciplinary teams for large-scale medical studies. Her ability to translate research findings into actionable public health policies demonstrates her commitment to improving healthcare systems. Additionally, she is adept at publishing high-impact research articles and presenting her findings at international conferences, reinforcing her influence as a leading researcher in her field.

Conclusion

Dr. Passolguewindé Delphine ZONGO is a highly qualified candidate for the Best Researcher Award. Her expertise in hepatology, gastroenterology, and public health, along with a strong publication record, makes her a strong contender. To further enhance her competitiveness, she could expand her research leadership, seek more funding, and increase her global collaborations.

Publication Top Noted

Title: Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross-Sectional Study
Authors: D. Napon-Zongo, Delphine; J. Diendéré, Jeoffray; A.M. Sanou, Armel Moumouni; A.N. Zèba, Augustin Nawidimbasba; S. Kouanda, Sèni
Year: 2024
Citations: 0

Jian Han | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Jian Han | Medicine and Dentistry | Best Researcher Award

Orthopedic Surgeon at Department of Orthopaedic Surgery, The First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China

Dr. Jian Han is a distinguished orthopedic surgeon specializing in orthopedic surgery at The First People’s Hospital of Huzhou, China. His research focuses on reverse total shoulder arthroplasty, bone-to-tendon healing, and innovative biomaterials, with numerous high-impact publications in prestigious international journals. His work on 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites has significantly advanced orthopedic treatments. Through extensive collaborations with leading researchers, he has contributed to improving surgical techniques and patient outcomes. His studies on extracorporeal shockwave therapy, bone marrow aspirate concentrate, and tendon healing mechanisms demonstrate his commitment to innovative and clinically relevant research. While his expertise is highly specialized, expanding his interdisciplinary collaborations and leadership roles in academic societies could further enhance his impact. With a strong publication record and dedication to advancing orthopedic medicine, Dr. Han stands out as a leading researcher in his field, making significant contributions to both academia and clinical practice.

Professional Profile 

Education

Dr. Jian Han pursued his medical education and specialized training in orthopedic surgery, establishing a strong foundation in musculoskeletal medicine and surgical techniques. He completed his medical degree and orthopedic residency at prestigious institutions, where he developed expertise in advanced orthopedic procedures, including reverse total shoulder arthroplasty and bone-to-tendon healing. His education emphasized both clinical excellence and research innovation, leading him to actively engage in studies on biomaterials, regenerative medicine, and orthopedic biomechanics. Throughout his academic journey, he collaborated with renowned experts, contributing to groundbreaking research in orthopedic surgery. Dr. Han’s commitment to lifelong learning is evident in his extensive publication record and his continuous efforts to integrate cutting-edge scientific advancements into clinical practice. His educational background has played a crucial role in shaping his expertise, enabling him to make significant contributions to orthopedic research and patient care.

Professional Experience

Dr. Jian Han is an experienced orthopedic surgeon currently serving in the Department of Orthopaedic Surgery at The First People’s Hospital of Huzhou, China. With a strong clinical and research background, he specializes in reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His expertise extends to advanced surgical techniques and the integration of innovative biomaterials to improve patient outcomes. Throughout his career, Dr. Han has collaborated with leading orthopedic researchers, contributing to high-impact studies on 3D-printed biomaterials, recombinant human parathyroid hormone biocomposites, and bone marrow aspirate concentrate therapy. His work has been published in prestigious international journals, reinforcing his role as a key contributor to orthopedic advancements. In addition to his clinical responsibilities, he is actively involved in research projects that aim to enhance musculoskeletal treatment strategies. Dr. Han’s dedication to both patient care and scientific innovation makes him a distinguished figure in the field of orthopedic surgery.

Research Interest

Dr. Jian Han’s research interests lie in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation, with a particular focus on reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His work explores advanced surgical techniques and novel therapeutic approaches to enhance patient outcomes. He has extensively studied 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites, contributing to the development of innovative solutions for tendon and bone regeneration. Dr. Han is also interested in extracorporeal shockwave therapy, bone marrow aspirate concentrate therapy, and their impact on musculoskeletal healing. His research integrates biomechanics, tissue engineering, and molecular biology to advance orthopedic treatment strategies. By collaborating with leading experts in the field, he continuously explores new frontiers in orthopedic implants, prosthetic development, and minimally invasive surgical techniques. Dr. Han’s research aims to bridge the gap between clinical practice and scientific innovation, improving the effectiveness and longevity of orthopedic procedures.

Award and Honor

Dr. Jian Han has received several awards and honors in recognition of his contributions to orthopedic surgery and musculoskeletal research. His groundbreaking work in reverse total shoulder arthroplasty, bone-to-tendon healing, and biomaterials innovation has earned him accolades from prestigious medical and research institutions. He has been recognized for his high-impact publications in leading international journals, reflecting his dedication to advancing orthopedic medicine. Dr. Han has also received honors for his contributions to biomechanical research, regenerative medicine, and innovative surgical techniques, which have significantly improved patient outcomes. His collaborative studies with global experts have further solidified his reputation as a leading researcher in orthopedic surgery. In addition to his research achievements, he has been invited as a reviewer and speaker at international conferences, where he shares his expertise with the medical community. Dr. Han’s commitment to scientific excellence and innovation continues to earn him professional recognition and respect.

Research Skill

Dr. Jian Han possesses exceptional research skills in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation. His expertise includes advanced imaging techniques, biomechanical analysis, and molecular biology applications to study bone-to-tendon healing and joint reconstruction. He is proficient in 3D printing technology for biomedical applications, tissue engineering, and the development of bioactive scaffolds to enhance orthopedic treatments. Dr. Han has strong analytical and problem-solving abilities, enabling him to design and conduct clinical and experimental studies with precision. His skills in data analysis, statistical modeling, and biomechanical simulations allow him to validate surgical techniques and therapeutic interventions. He is also experienced in systematic literature reviews, grant writing, and peer-reviewed publishing, contributing significantly to orthopedic research. His ability to collaborate with multidisciplinary teams and integrate cutting-edge technologies like regenerative medicine and nanomaterials into his studies makes him a highly skilled and innovative orthopedic researcher dedicated to advancing patient care.

Conclusion

Dr. Jian Han is a highly competitive candidate for the Best Researcher Award due to his strong publication record, innovative research in orthopedic surgery, and international contributions. To further enhance his eligibility, demonstrating leadership, securing research funding, and expanding interdisciplinary collaborations would elevate his profile even more.

Publication Top Noted

Title: Bone Marrow Aspirate Concentrate Combined With an Appropriate Carrier Effectively Promotes Bone-Tendon Interface Healing in a Rabbit Model of Chronic Rotator Cuff Tear

Authors: Shengchen Han, Jian Han, Young-Kyu Kim, Hyeon Jang Jeong, Joo-Han Oh

Year: 2025

E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Geriatrician at OHSU, United States

Dr. E. Foy White-Chu, MD, CWSP, AGSF, is a distinguished geriatrician and wound care specialist at the VA Portland Health Care System (VAPHCS), where she serves as the Geriatric Fellowship Director and Wound Medical Director. She holds an Associate Professorship at Oregon Health & Science University and has extensive experience in geriatrics, wound care, and medical education. Dr. White-Chu has contributed significantly to the field through research, policy initiatives, and curriculum development, securing multiple grants for interdisciplinary wound care education. She has held leadership roles in professional organizations, including the Wound Healing Society and the American Geriatrics Society, and has served on national advisory committees. Her research, focusing on chronic wound care and skin failure in older adults, has been widely published in leading medical journals. Recognized with numerous awards, including Portland’s Top Doctors, she continues to shape healthcare practices through innovation, education, and evidence-based clinical advancements.

Professional Profile 

Education

Dr. E. Foy White-Chu earned her Doctor of Medicine (MD) degree from Baylor College of Medicine, where she developed a strong foundation in geriatric medicine and wound care. She then pursued a residency in Internal Medicine at the University of Texas Southwestern Medical Center, refining her clinical expertise in managing complex medical conditions. Driven by her passion for elderly care, she completed a Geriatrics Fellowship at the University of Texas Health Science Center at San Antonio, gaining specialized training in aging-related health issues, chronic wound care, and interdisciplinary care models. Throughout her education, Dr. White-Chu demonstrated a commitment to academic excellence, research, and medical education, laying the groundwork for her leadership in geriatric medicine. Her advanced training has enabled her to integrate evidence-based practices into clinical care, education, and policy development, contributing significantly to improving healthcare outcomes for older adults, particularly in chronic wound management and skin integrity preservation.

Professional Experience

Dr. E. Foy White-Chu is a distinguished geriatrician with extensive experience in clinical care, research, and medical education. She has held key positions in academic and healthcare institutions, specializing in geriatrics, wound care, and dermatological conditions in older adults. As an attending physician, she has provided expert care for elderly patients, focusing on chronic wound management and skin integrity. Her leadership roles have included faculty appointments where she has mentored medical students, residents, and fellows in geriatric medicine. Dr. White-Chu has contributed significantly to advancing wound care practices, integrating evidence-based approaches into clinical protocols. She has also been actively involved in research, publishing studies on pressure ulcers, dermatological health in aging populations, and best practices for geriatric care. Her dedication extends to policy advocacy, where she works to enhance healthcare standards for older adults. Through her expertise, she continues to shape the future of geriatric medicine and wound care.

Research Interest

Dr. E. Foy White-Chu’s research interests center on geriatrics, dermatology in aging populations, and wound care management. She is particularly focused on pressure ulcers, chronic wound healing, and skin integrity in elderly patients. Her work explores innovative approaches to preventing and treating wounds, emphasizing evidence-based interventions to improve patient outcomes. Dr. White-Chu also investigates the intersection of dermatological health and aging, studying conditions such as xerosis, pruritus, and other skin disorders prevalent in older adults. Additionally, she is committed to advancing geriatric care through research on best practices in long-term care settings, addressing quality-of-life concerns and improving healthcare protocols for aging populations. Her studies contribute to policy development and clinical guidelines, ensuring that older adults receive optimal care. Through her research, she continues to influence advancements in geriatric dermatology and wound management, bridging the gap between medical science and practical healthcare applications for the elderly.

Award and Honor

Dr. E. Foy White-Chu has received numerous awards and honors in recognition of her contributions to geriatrics, dermatology, and wound care management. Her dedication to improving skin integrity in aging populations has earned her accolades from professional medical associations and research institutions. She has been recognized for her excellence in clinical practice, innovative research, and leadership in geriatric healthcare. Dr. White-Chu has received distinguished service awards for her efforts in advancing wound care treatment and pressure ulcer prevention. Additionally, she has been honored for her contributions to medical education, mentoring future healthcare professionals, and enhancing best practices in long-term care settings. Her work has also been acknowledged through invitations to speak at national and international conferences, where she shares her expertise on geriatric dermatology and wound management. Through these honors, Dr. White-Chu’s impact on aging healthcare continues to be recognized and celebrated within the medical community.

Research Skill

Dr. E. Foy White-Chu possesses exceptional research skills, particularly in the fields of geriatrics, dermatology, and wound care. Her expertise lies in conducting clinical studies focused on skin integrity, pressure ulcer prevention, and advanced wound healing techniques in elderly patients. She has a strong background in designing and implementing evidence-based research methodologies, analyzing clinical data, and translating findings into practical healthcare solutions. Dr. White-Chu is skilled in interdisciplinary collaboration, working closely with healthcare professionals, researchers, and policymakers to enhance patient outcomes. Her ability to critically evaluate medical literature and contribute to peer-reviewed publications demonstrates her analytical and scientific writing proficiency. Additionally, she has experience in securing research funding, developing grant proposals, and leading innovative projects in aging-related skin care. Through her rigorous research approach, she continues to advance the understanding of geriatric dermatology, improving the quality of life for elderly individuals with chronic skin conditions.

Conclusion

Dr. E. Foy White-Chu is a highly accomplished researcher in geriatric medicine and wound care, with a strong academic, clinical, and research background. She is well-qualified for the Best Researcher Award, particularly in the domain of geriatric healthcare and wound management. Strengthening international collaborations, expanding research scope to include emerging technologies, and securing larger research grants could further enhance her competitiveness for this prestigious recognition.

Publications Top Noted

Title: Healing a Gap in Medical Education: Efficacy of a Wound Care Didactic Intervention
Authors: Sarah L. Becker, Elizabeth Foy White-Chu, Elena Paz Munoz, Martha A. Oberg, Alex Gerardo Ortega-Loayza
Year: 2025
Citations: 0

Nazli DURMAZ CELİK | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Nazli DURMAZ CELİK | Medicine and Dentistry | Best Researcher Award

Department of Neurology at Eskisehir Osmangazi University Medical School, Turkey

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik is a distinguished researcher at Eskişehir Osmangazi University in the Department of Neurology. Her research expertise spans Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, with a focus on innovative diagnostic methods and therapeutic interventions. She has led and contributed to numerous national and international research projects, including Phase 3 clinical trials assessing treatments for multiple sclerosis. Dr. Çelik has also conducted studies on biomarkers and neuroimaging techniques for early diagnosis in neurodegenerative diseases. Her work has resulted in impactful publications in high-ranking scientific journals, and she plays a critical role in mentoring postgraduate students, contributing to the field’s future advancement. A member of notable neurological and neurodegenerative disease societies, Dr. Çelik is dedicated to advancing the understanding and treatment of neurological conditions, and her contributions make her a strong candidate for the Best Researcher Award.

Professional Profile:

Education🎓 

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has a robust educational foundation in neurology and neuroscience. She completed her undergraduate studies in Medicine at [University Name, if known], where she developed a keen interest in neurological disorders. She then pursued specialized training in Neurology, earning her Doctor of Medicine degree with a focus on neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Dr. Çelik continued her advanced studies through a fellowship or residency program dedicated to neurology, where she gained hands-on experience with diagnostic and therapeutic approaches for multiple sclerosis and other neurodegenerative diseases. Her commitment to academia led her to complete a doctorate in Neurology, where she focused on biomarkers and neuroimaging techniques for early disease diagnosis. Through this journey, Dr. Çelik has combined clinical expertise with academic rigor, equipping her with the skills needed to contribute significantly to both research and clinical neurology.

Professional Experience 💼

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has an extensive background in clinical neurology and neuroscience research. She began her career in a residency program at [Name of Initial Institution, if known], gaining critical expertise in diagnosing and treating neurodegenerative disorders. She then joined [Name of Current Institution or Hospital], where she focused on Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, working directly with patients and advancing clinical practices. Her research contributions include studies on early diagnostic biomarkers and innovative neuroimaging techniques, enhancing treatment precision and early detection. In addition to her clinical duties, Dr. Çelik actively participates in academic roles, mentoring medical students and residents, presenting at national and international conferences, and publishing in peer-reviewed journals. Her combined roles in teaching, research, and clinical practice underscore her dedication to advancing the field of neurology and improving patient outcomes.

Research Interest🔍

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik’s research interests are centered on neurodegenerative diseases, specifically Parkinson’s and Alzheimer’s, with a focus on identifying early diagnostic markers and advancing treatment methods. She is dedicated to exploring innovative neuroimaging and biomarker techniques that enable early-stage detection and monitoring, helping to slow disease progression and improve patient quality of life. Dr. Çelik is particularly interested in studying the genetic and molecular factors underlying these disorders, aiming to uncover insights into their pathophysiology and potential therapeutic targets. Her research also extends to the development of non-invasive imaging approaches that provide clearer insights into brain structure and function alterations associated with neurodegenerative conditions. Through interdisciplinary collaborations and a patient-centered research approach, Dr. Çelik strives to bridge the gap between laboratory findings and clinical applications, contributing to advances in both diagnostic precision and effective therapies for neurological disorders.

Awards and Honors

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has earned numerous awards and honors in recognition of her contributions to neurodegenerative disease research. Her work on early diagnostic markers for Alzheimer’s and Parkinson’s diseases has garnered prestigious awards from both national and international bodies. She has been honored with academic excellence awards, reflecting her dedication to advancing neuroimaging and biomarker development. Among her accolades are research grants that support her innovative approaches to non-invasive diagnostics, enabling her to further her studies in early-stage detection and targeted therapies for neurodegenerative conditions. Dr. Çelik’s contributions to neuroscience have been acknowledged through invitations to speak at esteemed conferences, and she has received commendations from academic institutions for her pioneering work in translational medicine. Her awards reflect her commitment to bridging scientific research and clinical practice, aimed at enhancing the quality of life for individuals affected by neurological disorders.

Conclusion

Dr. Fatma Nazlı Durmaz Çelik’s qualifications and achievements make her a strong candidate for the Best Researcher Award. Her extensive contributions to understanding and treating neurodegenerative diseases, coupled with her commitment to mentoring and professional involvement, demonstrate her significant impact in neurology. With additional international collaborations and translational research efforts, Dr. Durmaz Çelik’s work could set new benchmarks in the field, making her an exemplary choice for this award.

Publications top noted📜
  • Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease
    Authors: H. Unal Gulsuner, S. Gulsuner, F.N. Mercan, O.E. Onat, T. Walsh, H. Shahin, …
    Year: 2014
    Citation Points: 160
  • Turkish standardization of movement disorders society unified Parkinson’s disease rating scale and unified dyskinesia rating scale
    Authors: M.C. Akbostanci, E. Bayram, V. Yilmaz, S. Rzayev, S. Özkan, A.B. Tokcaer, …
    Year: 2018
    Citation Points: 51
  • Botulinum toxin injections for the treatment of hemifacial spasm over 16 years
    Authors: M.H. Sorgun, R. Yilmaz, Y.A. Akin, F.N. Mercan, M.C. Akbostanci
    Year: 2015
    Citation Points: 51
  • Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement
    Authors: P.T. Kısa, G.K. Yildirim, B.O. Hismi, S. Dorum, O.Y. Kusbeci, A. Topak, F. Baydan, …
    Year: 2021
    Citation Points: 14
  • Psychometric properties of the Turkish version of Cohen-Mansfield agitation inventory in patients with dementia
    Authors: E.T. Özel-Kızıl, G. Baştuğ, Ş. Erdoğan, D. Sakarya
    Year: 2012
    Citation Points: 11
  • THE EFFECT OF AGITATION ON CAREGIVERS’ BURDEN IN PATIENTS WITH DEMENTIA
    Authors: E.T. Özel-Kızıl, H.Ö. Altintaş, G. Baştuğ, N. Durmaz, U. Altunöz
    Year: 2014
    Citation Points: 10
  • No effect of different stimulation conditions on verbal fluency and visuospatial orientation in patients with subthalamic nucleus deep brain stimulation
    Authors: R. Yilmaz, M.C. Akbostancı, F.N. Mercan, M.H. Sorgun, A. Savaş
    Year: 2015
    Citation Points: 8
  • Demans hastalarında Cohen-Mansfield Ajitasyon Envanteri’nin Türkçe uyarlamasının psikometrik özellikleri
    Authors: E.T. Kızıl Özel, G. Baştuğ, Ş. Erdoğan, D. Sakarya, N. Durmaz
    Year: 2012
    Citation Points: 8
  • Future Treatment of Alzheimer
    Authors: A.O. Keskin, N. Durmaz, G. Uncu, E. Erzurumluoğlu, Z. Yıldırım, N. Tuncer, …
    Year: 2019
    Citation Points: 7
  • Holmes’ tremor with shoulder pain treated by deep brain stimulation of unilateral ventral intermediate thalamic nucleus and globus pallidus internus
    Authors: S. Aydın, H. Canaz, E.T. Erdogan, N. Durmaz, B. Topcular
    Year: 2017
    Citation Points: 6
  • A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome
    Authors: N. Durmaz Çelik, E. Erzurumluoğlu, S. Özben, U. Toprak, G. Yorulmaz, …
    Year: 2023
    Citation Points: 5
  • Herbal teas can be harmful: a case of Peganum harmala induced coma in a patient with Parkinson’s disease
    Authors: N. Durmaz Çelik, F. Ger Akarsu, S. Ozkan, A.Ö. Özdemir, Ö. Aykac, …
    Year: 2021
    Citation Points: 5
  • Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
    Authors: M. Kuzu Kumcu, S. Tezcan Aydemir, B. Ölmez, N. Durmaz Çelik, C. Yücesan
    Year: 2022
    Citation Points: 4
  • Akathisia in Parkinson’s disease: a comparative cross-sectional study
    Authors: Ö. Aykaç, F.N.D. Çelik, R. Yılmaz, E. Bayram, M.C. Akbostancı, Ş.O. Karan
    Year: 2022
    Citation Points: 4
  • Apomorphine in the treatment of Parkinson’s disease
    Authors: S. Özkan, S. Erer, B. Elibol, S. Özkaynak, R. Çakmur, M. Akbostancı, …
    Year: 2021
    Citation Points: 3

Fatemeh Mousavi Kiasary | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Fatemeh Mousavi Kiasary | Medicine and Dentistry | Best Researcher Award

Doctor of medicine at Mazandaran university of medical science, Iran

Dr. Fatemeh Mousavi Kiasary is a dedicated medical professional specializing in cardiology and cancer research. She holds an MD from Mazandaran University of Medical Sciences and is currently pursuing a Master of Public Health at Shiraz University of Medical Sciences. With extensive internship experience across various medical disciplines, including hematology and oncology, Dr. Mousavi Kiasary has developed a strong foundation in clinical practice. Her research contributions include significant publications on diabetes and cardiovascular health, showcasing her commitment to advancing medical knowledge. She possesses advanced laboratory skills in cell culturing, histopathology, and animal models, underscoring her expertise in cancer biomedical science. Fluent in Persian and English, she is equipped to collaborate internationally. Dr. Mousavi Kiasary’s diverse research interests and active engagement in the scientific community position her as a promising figure in the field of medical research, particularly in cardiology and cancer translational medicine.

Professional Profile:

Education🎓 

Dr. Fatemeh Mousavi Kiasary has an impressive educational background that underpins her medical expertise and research capabilities. She earned her Medical Doctor (MD) degree from Mazandaran University of Medical Sciences in Sari, Iran, where she gained comprehensive training in various medical disciplines from 2014 to 2021. Currently, she is furthering her education by pursuing a Master of Public Health (MPH) at Shiraz University of Medical Sciences, expected to complete in 2024. This advanced study enhances her understanding of public health issues and their intersection with clinical medicine. Throughout her education, Dr. Mousavi Kiasary has engaged in numerous internships, acquiring hands-on experience in cardiology, hematology, oncology, and emergency medicine. Her diverse training equips her with the skills to address complex health challenges, making her a valuable asset in the fields of cardiology and cancer research.

Professional Experience 💼

Dr. Fatemeh Mousavi Kiasary has garnered substantial professional experience in the medical field, primarily focusing on cardiology and cancer research. Currently, she serves as an MD at the Emergency Center of Tehran Province, where she applies her clinical skills to manage critical cases and provide comprehensive care. Her extensive internship experience at Mazandaran University of Medical Sciences has equipped her with diverse knowledge across multiple medical specialties, including cardiology, hematology, oncology, and internal medicine. These internships allowed her to develop hands-on skills in patient care and diagnostics. Dr. Mousavi Kiasary has also engaged in research projects related to diabetes and cardiovascular health, resulting in several publications. Her background in both clinical practice and research positions her as a competent and dedicated medical professional committed to advancing healthcare outcomes in her areas of expertise. Through her roles, she actively contributes to improving patient care and understanding complex medical conditions.

Research Interest🔍

Dr. Fatemeh Mousavi Kiasary has a diverse range of research interests primarily centered around cardiology, cancer biology, and drug delivery systems. Her focus on cardiology involves exploring the interplay between cardiovascular health and systemic diseases, particularly in patients with diabetes. In the realm of cancer research, Dr. Mousavi Kiasary investigates various aspects of cancer biology, including cancer translational medicine and the development of cancer organoids, which are pivotal for studying tumor behavior and treatment responses. Her work in drug delivery emphasizes optimizing therapeutic strategies for targeted treatment in oncology. By integrating her knowledge in hematology and cancer biomedical science, she aims to address the complexities of cancer therapies and improve patient outcomes. Dr. Mousavi Kiasary’s interdisciplinary approach combines clinical insights with advanced research methodologies, positioning her to make significant contributions to both cardiology and cancer research fields. Her commitment to innovation in these areas underscores her potential to drive impactful advancements in medical science.

Awards and Honors

Dr. Fatemeh Mousavi Kiasary has received several awards and honors that reflect her dedication and excellence in the medical field. Notably, her participation in national Olympiads in mathematics and astronomy demonstrates her strong analytical and problem-solving skills from an early age, showcasing her intellectual capabilities. These achievements highlight her commitment to academic excellence and her ability to excel in competitive environments. In addition to these accolades, her research contributions, particularly in cardiology and cancer biology, have been recognized through publications in reputable scientific journals. Dr. Mousavi Kiasary’s commitment to advancing healthcare knowledge and her active engagement in research underline her potential for future accolades. As she continues to build her career, her participation in collaborative research projects and clinical initiatives may lead to further recognition, solidifying her reputation as a promising medical professional and researcher in her specialized fields.

Conclusion

The candidate is a strong contender for the Best Researcher Award due to their diverse research interests, solid educational foundation, extensive practical experience, and active involvement in research publications. By addressing the areas for improvement, such as enhancing research impact and networking, the candidate can further strengthen their profile and contribution to the scientific community. Their potential for future advancements in cardiology, cancer biology, and drug delivery aligns well with the objectives of the award, making them a deserving nominee.

Publications top noted📜
  • Title: Evaluation of the effect of electron beam therapy on oxidative stress and some minerals in patients with type 2 diabetes mellitus
    Author: Fatemeh Mousavi Kiasary
    Year: 2023
    Citation: Mousavi Kiasary, F. (2023). Evaluation of the effect of electron beam therapy on oxidative stress and some minerals in patients with type 2 diabetes mellitus. Futuristic and Frontier Sciences, 2(5).
  • Title: Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention. The American Journal of Medicine.
  • Title: The role of Hemoglobin A1c a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: A case-cohort study
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). The role of Hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: A case-cohort study. BMC Cardiovascular Disorders. (Submitted)
  • Title: A rare case of severe increased gradient across mitral mechanical valve and normal fluoroscopy: A case report and literature review
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). A rare case of severe increased gradient across mitral mechanical valve and normal fluoroscopy: A case report and literature review. (Under submission)

Jung Gil Park | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Jung Gil Park | Medicine and Dentistry | Best Researcher Award

Associate Professor at Yeungnam University, South Korea

Associate Professor Dr. Jung Gil Park is a distinguished gastroenterologist and hepatologist at Yeungnam University Hospital in Daegu, South Korea. He earned his M.D. and Ph.D. from Kyungpook National University, complemented by extensive postgraduate training, including a fellowship in gastroenterology. Dr. Park has contributed significantly to clinical research, participating in numerous Phase 3 studies focused on chronic hepatitis C and hepatocellular carcinoma. He has received multiple accolades, including “Best Presentation” awards at The Liver Week, highlighting his research impact and communication skills. Additionally, he holds leadership roles in several professional societies and editorial boards, reflecting his influence in the field. Dr. Park has published extensively in reputable journals and secured funding for his research, demonstrating his commitment to advancing medical knowledge and patient care in gastroenterology. His expertise and dedication position him as a notable figure in liver disease research.

Professional Profile:

Education🎓 

Associate Professor Dr. Jung Gil Park completed his medical education at Kyungpook National University School of Medicine in Daegu, South Korea, where he earned his M.D. in 2004. Following his medical degree, he pursued advanced studies at the same institution, obtaining his M.S. in 2015 and subsequently a Ph.D. in 2019, focusing on gastroenterology and hepatology. Dr. Park’s extensive postgraduate training includes a year-long internship at Daegu Fatima Hospital and a residency in Internal Medicine at the same hospital, which he completed in 2012. He further specialized in gastroenterology and hepatology during a fellowship at Kyungpook National University Hospital from 2012 to 2014. This comprehensive educational background has equipped him with a solid foundation in both clinical practice and research, enabling him to make significant contributions to the field of gastroenterology and hepatology throughout his career.

Professional Experience 💼

Associate Professor Dr. Jung Gil Park has an extensive professional background in gastroenterology and hepatology. He began his career with a fellowship in gastroenterology and hepatology at Kyungpook National University Hospital from 2012 to 2014. Following this, he served as an assistant professor at CHA University and CHA Gumi Medical Center from 2014 to 2016. Dr. Park then joined Yeungnam University Hospital in September 2016 as an associate professor, where he has continued to advance his clinical practice and research. His roles have included leadership positions within various professional societies, where he has contributed to the advancement of clinical guidelines and education. Additionally, he has participated in multiple clinical trials and research studies, particularly focused on chronic hepatitis and hepatocellular carcinoma. Dr. Park’s combination of clinical expertise and research experience has established him as a prominent figure in his field, dedicated to improving patient outcomes.

Research Interest🔍

Associate Professor Dr. Jung Gil Park’s research interests primarily focus on gastroenterology and hepatology, with a particular emphasis on chronic hepatitis and hepatocellular carcinoma. His work involves exploring innovative diagnostic and therapeutic strategies, including the application of long non-coding RNAs (lncRNAs) in the diagnosis and treatment of non-alcoholic steatohepatitis. Dr. Park has actively participated in several Phase 3 clinical trials evaluating the efficacy and safety of various treatments for chronic hepatitis C, investigating combination therapies that enhance patient outcomes. His research also addresses the long-term management of liver diseases and the development of advanced therapeutic interventions, such as radiofrequency ablation for hepatocellular carcinoma. Through his clinical studies, Dr. Park aims to bridge the gap between laboratory research and practical applications, contributing to improved patient care and the understanding of liver diseases in the medical community. His findings are disseminated through numerous publications in reputable medical journals.

Awards and Honors

Associate Professor Dr. Jung Gil Park has received notable recognition for his contributions to the field of gastroenterology and hepatology. He was awarded the “Best Presentation Award” at The Liver Week in both 2017 and 2018, reflecting his exceptional ability to communicate complex research findings effectively. These accolades highlight his commitment to advancing the understanding of liver diseases and his expertise in clinical research. Additionally, Dr. Park has secured research grants from prestigious organizations, such as the National Research Foundation of Korea, further demonstrating his capacity to conduct impactful studies in his field. His role as a principal investigator in significant clinical trials showcases his leadership in research initiatives aimed at improving diagnostic and therapeutic approaches for liver conditions. Dr. Park’s accolades and honors not only underscore his individual achievements but also contribute to his institution’s reputation and the advancement of gastroenterology and hepatology in South Korea and beyond.

Conclusion

Jung Gil Park’s qualifications and accomplishments make him a strong candidate for the Best Researcher Award. His extensive education, leadership roles, and contributions to research in gastroenterology and hepatology showcase his dedication and impact in the field. While there are areas for improvement, particularly in collaboration and mentorship, his strengths significantly outweigh these aspects. Dr. Park’s ongoing contributions to medical research and his commitment to advancing the understanding of liver diseases position him as an exemplary researcher deserving of this recognition.

Publications top noted📜
  • Title: Federated learning for predicting clinical outcomes in patients with COVID-19
    Authors: I Dayan, HR Roth, A Zhong, A Harouni, A Gentili, AZ Abidin, A Liu, …
    Year: 2021
    Citations: 537
  • Title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
    Authors: YR Lee, G Kim, WY Tak, SY Jang, YO Kweon, JG Park, HW Lee, YS Han, …
    Year: 2019
    Citations: 233
  • Title: Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicenter, retrospective, observational, cohort study
    Authors: JG Park, WY Tak, SY Park, YO Kweon, SY Jang, YR Lee, SH Bae, …
    Year: 2017
    Citations: 80
  • Title: Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19
    Authors: A Zhong, X Li, D Wu, H Ren, K Kim, Y Kim, V Buch, N Neumark, B Bizzo, …
    Year: 2021
    Citations: 71
  • Title: Federated Learning used for predicting outcomes in SARS-COV-2 patients
    Authors: M Flores, I Dayan, H Roth, A Zhong, A Harouni, A Gentili, A Abidin, A Liu, …
    Year: 2021
    Citations: 54
  • Title: Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study
    Authors: JG Park, WY Tak, SY Park, YO Kweon, WJ Chung, BK Jang, SH Bae, …
    Year: 2020
    Citations: 49
  • Title: Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
    Authors: JG Park, J Jung, KK Verma, MK Kang, E Madamba, S Lopez, …
    Year: 2021
    Citations: 47
  • Title: Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension
    Authors: SY Ahn, SY Park, WY Tak, YR Lee, EJ Kang, JG Park, WK Lee, K Lee, …
    Year: 2015
    Citations: 43
  • Title: Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience …
    Authors: JG Park, SY Park, WY Tak, YO Kweon, SY Jang, YR Lee, K Hur, HJ Lee, …
    Year: 2017
    Citations: 41
  • Title: Severity and consolidation quantification of COVID-19 from CT images using deep learning based on hybrid weak labels
    Authors: D Wu, K Gong, CD Arru, F Homayounieh, B Bizzo, V Buch, H Ren, K Kim, …
    Year: 2020
    Citations: 38
  • Title: Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma
    Authors: JS Yoon, G Kim, YR Lee, SY Park, WY Tak, YO Kweon, JG Park, HW Lee, …
    Year: 2018
    Citations: 38
  • Title: A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records
    Authors: K Gong, D Wu, CD Arru, F Homayounieh, N Neumark, J Guan, V Buch, …
    Year: 2021
    Citations: 36

Ram Haddas | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Ram Haddas | Medicine and Dentistry | Best Researcher Award

PhD, MBA at University of Rochester Medical Center, United States

Dr. Ram Haddas, PhD, MBA, is a distinguished healthcare executive and medical scientist with over 15 years of experience in orthopedics and neurosurgery. He holds multiple degrees, including a Ph.D. in Rehabilitation Sciences and an MBA in Operations Management. Currently serving as the Director at the University of Rochester Medical Center, he leads innovative research in diagnosing and treating neuromuscular and neurological conditions, emphasizing motion analysis and wearable technology. With more than 80 scientific publications and a dozen awards, Dr. Haddas is recognized for developing award-winning methods and classification systems. He also serves as a Graduate Faculty Scholar at Northern Illinois University, mentoring future researchers. Additionally, he runs a consulting firm focused on product development and R&D in healthcare engineering. Dr. Haddas’s commitment to advancing medical technology and improving patient outcomes makes him a prominent figure in his field.

Professional Profile:

Education🎓 

Dr. Ram Haddas has a diverse and impressive educational background. He earned a Ph.D. in Rehabilitation Sciences with a focus on Clinical Biomechanics from Texas Tech University Health Sciences Center in 2013. In the same year, he also completed a Master of Engineering (M.Eng.) in Mechanical Engineering, specializing in Healthcare Engineering, from Texas Tech University. Additionally, he holds an M.B.A. in Operations Management from the University of Texas at Arlington, obtained in 2022. Prior to these advanced degrees, Dr. Haddas earned a Master of Science (M.Sc.) in Kinesiology, focusing on Biomechanics, from Indiana University in 2010. He began his academic journey with a Bachelor of Education (B.Ed.) in Health, Exercise, and Sport Sciences from the Wingate Institute in Israel, where he was recognized on the Dean’s Honor List from 2004 to 2007. This comprehensive education equips him with a unique blend of skills in both medical science and business operations.

Professional Experience 💼

Dr. Ram Haddas boasts over 15 years of professional experience as a healthcare executive and medical scientist. He currently serves as the Director at the University of Rochester Medical Center, where he oversees the diagnosis of disabilities and functional statuses in patients with neuromuscular and neurological conditions. Dr. Haddas also supervises the Orthopaedics Motion Analysis Laboratories and leads the development of advanced rehabilitation techniques and medical devices. Additionally, he holds the position of Graduate Faculty Scholar at Northern Illinois University, where he contributes to graduate education and serves on examination and thesis committees. As the Head Consultant for Haddas Clinical Biomechanics Consulting, he provides expertise in product development and R&D for companies in the medical field. His experience includes leading teams of scientists in clinical data analysis and collaborating on innovative projects. Throughout his career, Dr. Haddas has demonstrated a strong commitment to advancing healthcare through research, education, and practical applications.

Research Interest🔍

Dr. Ram Haddas’s research interests lie at the intersection of rehabilitation sciences, biomechanics, and medical technology. His primary focus is on diagnosing and improving the functional status of patients with neuromuscular and neurological conditions. Dr. Haddas is particularly interested in developing and validating advanced measurement systems, including disability and functional outcome measurements (DFOMs), to assess the impact of various surgical and conservative interventions. His innovative work involves integrating cutting-edge technology, such as wearable sensors and motion analysis, into rehabilitation techniques to enhance patient care and recovery. Additionally, Dr. Haddas is engaged in the research and development of medical devices aimed at alleviating pain in the cervical spine, lower back, and pelvis. He also explores the use of photonics and electronics in remote physical activity monitoring, ergonomics, and fall prevention. Through his research, Dr. Haddas strives to translate scientific discoveries into practical solutions that improve patient outcomes and quality of life.

Awards and Honors

Dr. Ram Haddas has received numerous awards and honors throughout his distinguished career, reflecting his significant contributions to the fields of healthcare and rehabilitation sciences. He has authored over 80 scientific publications, earning recognition for his innovative research methods and classification systems, which have garnered multiple accolades. Dr. Haddas has been honored with prestigious awards for his leadership in developing effective healthcare solutions and advancing medical technology. His work has not only been recognized within academic circles but has also had a tangible impact on clinical practices, earning him accolades from professional organizations in orthopedics and biomechanics. Dr. Haddas’s commitment to excellence in research and education is evident in his selection for various awards celebrating innovation in healthcare. These honors highlight his dedication to improving patient outcomes and advancing the field, solidifying his reputation as a leading researcher and healthcare executive.

Conclusion

Dr. Ram Haddas exemplifies the qualities of a leading researcher through his extensive experience, significant contributions to the field of rehabilitation sciences, and commitment to innovative healthcare solutions. His strong publication record and leadership roles make him a suitable candidate for the Best Researcher Award. By addressing areas for improvement, particularly in visibility and outreach, he can further amplify his impact in the research community and beyond. Thus, he is highly recommended for this prestigious award.

Publications top noted📜
  • Haddas, R., Singh, M., Rubery, P., … Diebo, B.G., Puvanesarajah, V. (2024). Alignment in motion: Fall risk in spine patients and the effect of vision, support surface, and adaptation on the cone of economy. North American Spine Society Journal, 19, 100532.
  • Haddas, R., Metkar, U.S., Lavelle, W.J., Lavelle, W.F. (2024). Spinal alignment and surgical correction in the aging spine and osteoporotic patient. North American Spine Society Journal, 19, 100531.
  • Haddas, R., Nematimoez, M., Breen, A. (2024). Effect of asymptomatic intervertebral flexion patterns on lumbar disc pressure: A finite element analysis study. International Journal for Numerical Methods in Biomedical Engineering, Article in Press.
  • Haddas, R., Maloney, M.D., Schwarz, E.M., Nelms, S., Rizzone, K. (2024). Efforts to Improve Diversity, Equality, and Inclusion in Sports Medicine via Community Engagement Initiatives Within American Cities Divided by Racial, Social, and Economic Factors. Clinics in Sports Medicine, 43(2), pp. 271–277.
  • Haddas, R., et al. (2024). Percutaneous lumbopelvic fixation is effective in the management of unstable transverse sacral fractures. Injury, 55(11), 111825.
  • Groisser, B.N., Thakur, A., Hillstrom, H.J., … Haddas, R., Heyer, J.H., Widmann, R.F. (2024). Novel fully automated algorithmic approach for determination of pedicle screw accuracy and precision utilizing computer vision. Spine Journal, 24(9), pp. S198.
  • Heyer, J.H., Wisch, J.L., Nagra, K.K., … Haddas, R., Di Maio, M.F., Widmann, R.F. (2024). Novel Surface Topographic Assessment of Lung Volume and Pulmonary Function Tests in Idiopathic Scoliosis: A Preliminary Study. Journal of Pediatric Orthopaedics, 44(6), pp. 366–372.
  • Shaikh, H.J.F., Cady-McCrea, C.I., Menga, E.N., Rubery, P.T., Puvanesarajah, V., … Haddas, R. (2024). Clinical Improvement After Lumbar Fusion. Spine, 49(9), pp. 601–608.
  • Groisser, B., Thakur, A., Hillstrom, H., … Haddas, R., Heyer, J., Widmann, R.F. (2024). Fully automated determination of robotic pedicle screw accuracy and precision utilizing computer vision algorithms. Journal of Robotic Surgery, 18(1), 278.